Mergers & Acquisitions

Fulgent Genetics

04/22
|
$170.0 Million
Piper Sandler served as buy-side advisor for Fulgent Genetics on acquisition of Inform Diagnostics, a portfolio company of Avista Capital Partners
Sub-Type
Buy-Side
Sub-Sector
Life Sciences Tools & Diagnostics